ID
25902
Beschreibung
Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876
Link
https://clinicaltrials.gov/ct2/show/NCT00291876
Stichworte
Versionen (2)
- 23.08.17 23.08.17 -
- 26.09.17 26.09.17 -
Hochgeladen am
26. September 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876
Beschreibung
NON-SERIOUS ADVERSE EVENTS
Beschreibung
(Please report all serious adverse events only on the Serious Adverse Event (SAE) form).
Datentyp
text
Alias
- UMLS CUI [1]
- C1518404
Beschreibung
NON-SERIOUS ADVERSE EVENTS
Beschreibung
adverse event number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0449788
Beschreibung
adverse event description
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0678257
Beschreibung
comment
Datentyp
text
Alias
- UMLS CUI [1]
- C0947611
Beschreibung
adverse event location
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0450429
- UMLS CUI [1,3]
- C0205276
Beschreibung
adverse event location2
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0450429
Beschreibung
adverse event start date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697888
Beschreibung
immediate post-vaccination reaction
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2697888
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C0042196
Beschreibung
adverse event end date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697886
Beschreibung
adverse event intensity
Datentyp
integer
Alias
- UMLS CUI [1]
- C1710066
Beschreibung
causality
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C3641099
- UMLS CUI [1,2]
- C0877248
Beschreibung
Adverse Event Outcome
Datentyp
text
Alias
- UMLS CUI [1]
- C1705586
Ähnliche Modelle
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876
C0600091 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
C0678257 (UMLS CUI [1,2])
C0450429 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0450429 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C0877248 (UMLS CUI [1,2])
Keine Kommentare